Position in IRD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,623,750
-$472,250 QoQ
Shares Held
1,125,000
+0.4% QoQ
Ownership
1.35%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#18
of 102 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IRD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Opaleye Management Inc. holds $678,840,611 across 50 Biotechnology names. IRD ranks #32 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IRON |
Disc Medicine, Inc.
|
855,000 | $62,534,700 | |
| 2 | URGN |
UroGen Pharma Ltd.
|
1,439,996 | $52,991,852 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
390,000 | $51,764,700 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
3,550,000 | $47,960,500 | |
| 5 | SLGL |
Sol-Gel Technologies Ltd.
|
500,000 | $37,070,000 | |
| 6 | RZLT |
Rezolute, Inc.
|
6,300,000 | $32,760,000 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
535,000 | $29,392,900 | |
| 8 | IMMX |
Immix Biopharma, Inc.
|
2,345,000 | $24,176,950 |
All Filings in IRD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,623,750 | 1,125,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,096,000 | 1,120,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,251,200 | 1,120,000 | Shares | Sole | 2026-04-13 | |
| 2025-09-30 | $1,815,000 | 1,100,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,146,800 | 1,220,000 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,151,500 | 1,175,000 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||